BERLEX LABORATORIES, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 2138
 
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
 
 
C07D HETEROCYCLIC COMPOUNDS 1161
 
 
 
C07K PEPTIDES 1135
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6692763 Methods for treating postmenopausal women using ultra-low doses of estrogenJul 11, 00Feb 17, 04[A61K, A61F, A61M]
5891868 Methods for treating postmenopausal women using ultra-low doses of estrogenNov 21, 97Apr 06, 99[A31K, A61F]
5378816 Methods for high purity chromatographic separation of proteins having EGF-like binding domainsDec 16, 92Jan 03, 95[A61K]
5376567 Expression of interferon genes in Chinese hamster ovary cellsJan 09, 92Dec 27, 94[A61K, C12N, C07K]
5166344 Process for the preparation of imidazoquinoxalinonesSep 19, 91Nov 24, 92[C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2008/0119,449 METHODS FOR TREATING POSTMENOPAUSAL WOMEN USING ULTRA-LOW DOSES OF ESTROGENAbandonedDec 03, 07May 22, 08[A61K, A61P]
2005/0250,750 Methods for treating postmenopausal women using ultra-low doses of estrogenAbandonedSep 03, 03Nov 10, 05[A61K]
6887865 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02May 03, 05[A61K, C07D]
6864263 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02Mar 08, 05[A61K, C07D]
6849739 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02Feb 01, 05[C07D]
6846829 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02Jan 25, 05[A61K, C07D]
6841673 N-heterocyclic derivatives as nos inhibitorsExpiredApr 12, 02Jan 11, 05[C07D]
6841674 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02Jan 11, 05[C07D]
6747031 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02Jun 08, 04[A61K, C07D]
6686364 Benzamidine derivatives and their use as anti-coagulantsExpiredAug 07, 01Feb 03, 04[A61K, C07D]
6686367 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulantsExpiredJan 24, 03Feb 03, 04[A61K, C07D]
6670473 N-heterocyclic derivatives as NOS inhibitorsExpiredApr 12, 02Dec 30, 03[C07D]
6559147 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulantsExpiredMay 04, 01May 06, 03[A61K, C07D]
6552030 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulantsExpiredMay 04, 01Apr 22, 03[A61K, C07D]
2003/0073,669 N-heterocyclic derivatives as NOS inhibitorsAbandonedApr 12, 02Apr 17, 03[A61K, C07D]
6498185 Ortho-anthranilamide derivatives as anti-coagulantsExpiredAug 03, 00Dec 24, 02[A01N]
6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulantsExpiredMay 04, 01Dec 17, 02[A61K, C07D]
6495684 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulantsExpiredMay 04, 01Dec 17, 02[A61K, C07D]
6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulantsExpiredMay 04, 01Dec 10, 02[A61K, C07D]
6479485 Benzamidine derivatives and their use as anti-coagulantsExpiredAug 07, 01Nov 12, 02[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.